A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for glaucoma, the drops are now repurposed for presbyopia (age-related ...

As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...

For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...

For millions of adults, aging brings a familiar frustration: difficulty focusing on close-up objects such as books, smartphones, or small print. Traditionally, reading glasses or surgery have been the ...

Patients with presbyopia had consistent and durable vision improvement across multiple doses of a combination eye drop solution, a large retrospective review showed. From 69% to 99% of patients had ...

The FDA has approved a first-of-its-kind eye drop that addresses a common vision condition. The once-daily drops will treat an age-related condition that causes blurry near vision. The drops are ...

In a quiet but potentially transformative development for millions of Americans, the U.S. Food and Drug Administration (FDA) has approved a new type of daily eye drop that restores near vision without ...

People with so-called "resting squint face" may seem like they are perpetually angry, but they may just be having trouble seeing. Focusing on close objects becomes increasingly difficult as people age ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage signals, helping the body mount a defense. But when TLR signaling veers off ...

Please provide your email address to receive an email when new articles are posted on . Progressive myopia is a growing issue in every country as near vision demands for children continue to increase.